bezafibrate has been researched along with Nephrotic Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuyama, M; Hashimoto, T; Hayasaka, K; Matsunaga, A; Ogino, D; Toyoda, K | 1 |
| Arai, T; Himeno, S; Kanayama, Y; Kiriyama, K; Manabe, N; Matsuzaki, T; Matsuzawa, Y; Yamane, M; Yamashita, S | 1 |
| Baker, FE; Walls, J; Williams, AJ | 1 |
3 other study(ies) available for bezafibrate and Nephrotic Syndrome
| Article | Year |
|---|---|
Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Apolipoproteins E; Bezafibrate; Child; Child, Preschool; Enalapril; Female; Hematuria; Humans; Hypolipidemic Agents; Kidney Diseases; Kidney Failure, Chronic; Kidney Glomerulus; Nephrotic Syndrome; Probucol; Tetrazoles; Valine; Valsartan | 2009 |
Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy.
Topics: Adult; Apolipoprotein E2; Apolipoproteins E; Bezafibrate; Cholesterol, HDL; Female; High-Density Lipoproteins, Pre-beta; Humans; Hypolipidemic Agents; Kidney Diseases; Kidney Glomerulus; Lipoproteins; Lipoproteins, HDL; Nephrotic Syndrome; Thrombosis | 2003 |
The effect of bezafibrate on hyperlipidaemia in experimental nephrotic syndrome in rats.
Topics: Animals; Bezafibrate; Blood Proteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Hyperlipidemias; Nephrotic Syndrome; Protein Binding; Rats; Rats, Inbred Strains; Time Factors; Triglycerides | 1985 |